Prediction tacrolimus blood levels based on the Bayesian method in adult kidney transplant patients (Q43877187)

27 November 2017

title

Prediction tacrolimus blood levels based on the Bayesian method in adult kidney transplant patients (English)

1 reference

27 November 2017

Marie Antignac

1

1 reference

27 November 2017

Christine Fernandez

2

1 reference

27 November 2017

Benoît Barrou

3

1 reference

27 November 2017

Mariona Roca

4

1 reference

27 November 2017

Jean-Louis Favrat

5

1 reference

27 November 2017

Saïk Urien

6

1 reference

27 November 2017

Robert Farinotti

7

1 reference

27 November 2017

publication date

24 February 2011

1 reference

European Journal of Drug Metabolism and Pharmacokinetics

27 November 2017

published in

1 reference

27 November 2017

volume

36

1 reference

27 November 2017

issue

1

1 reference

27 November 2017

page(s)

25-33

1 reference

https://scigraph.springernature.com/pub.10.1007/s13318-011-0027-z

27 November 2017

exact match

0 references

cites work

Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Population pharmacokinetics II: estimation methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

First clinical experience with the new once-daily formulation of tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

The pharmacogenetics of calcineurin inhibitors: one step closer toward individualized immunosuppression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

International Federation of Clinical Chemistry/International Association of Therapeutic Drug Monitoring and Clinical Toxicology working group on immunosuppressive drug monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Pharmacokinetics of tacrolimus in liver transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

CYP3A5 *1 allele: impacts on early acute rejection and graft function in tacrolimus-based renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Influence of CYP3A5 genetic polymorphism on tacrolimus daily dose requirements and acute rejection in renal graft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Some suggestions for measuring predictive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Population pharmacokinetics of tacrolimus in adult kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Population pharmacokinetics. A regulatory perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Clinical pharmacokinetics of tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Population pharmacokinetic estimation of tacrolimus apparent clearance in adult liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Influence of CYP3A5 and MDR1 polymorphisms on tacrolimus concentration in the early stage after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation

21 January 2018

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of FK 506 in pediatric patients receiving living-related donor liver transplantations

1 reference

12 December 2020

FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects

1 reference

12 December 2020

A whole blood FK 506 assay for the IMx analyzer

1 reference

12 December 2020

Analysis of tacrolimus (FK 506) in relation to therapeutic drug monitoring.

1 reference

12 December 2020

Adaptive control of drug dosage regimens using maximum a posteriori probability Bayesian fitting.

1 reference

12 December 2020

Evaluation of the tacrolimus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients

1 reference

12 December 2020

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

1 reference

12 December 2020

Population pharmacokinetics and bioavailability of tacrolimus in kidney transplant patients

1 reference

12 December 2020

10.1007/S13318-011-0027-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

27 November 2017

1007143863

0 references

1 reference